Medical research funding the development of a new bronchiolitis vaccine for people over 60 and pregnant women.

New bronchiolitis vaccineproduced by the pharmaceutical company Pfizer, is aimed at over 60 years of age and pregnant women between 24 and 36 weeks, but it’s worth it 234.95 euros at the pharmacy. This has been authorized by the Spanish Medicines Agency and the Ministry of Health is now assessing the possibility include it in the national health system to make it more accessible.

Lorenzo Armenteros, physician and representative of the Spanish Society of General and Family Physicians (SEMG), advocates “ Financing in the most versatile wayto cover all ages for which the vaccine is indicated, as this will achieve reduce the number of hospitalizations by 90% this disease, as happened with infants.

Consider it to be very useful for older people“whereas symptoms and effects are similar to those of influenza and COVID viruses, with involvement that may not only be pulmonary, but also systemic, resulting in multiorgan changes.”

The SEMG spokesperson also believes the vaccine has shown positive results in women. pregnant. “The intention is for the vaccine to reach the fetus, and although they may receive similar immunization when they are still babies, this is beneficial given that Syncytial virus causes about 60% of infections acute respiratory infections in infants,” says Armenteros.

In its turn, Amos Garcia, head of the epidemiological service of the Canary Islands, emphasizes that “starting from the age of 60, the consequences of respiratory diseases worsen.” For this reason, he evaluates “all new products positively.” Estimated one in 10 hospitalizationsespecially among children under five years of age, due to bronchiolitis.